A multicenter, Cluster-Randomized, Active-Controlled, Single-Blind trial of Community-Based health education programs for the early detection of, and vaccination against, COVID-19 and the adoption of Self-Protective measures of hong kong residents
NCT ID NCT05539482
First seen Sep 10, 2026 ยท Last updated Sep 10, 2026
Summary
This study evaluates the community-based health education program in improving early testing for COVID-19, increasing vaccination acceptability and enhancing emergency preparedness and self-protection measures against COVID-19 in HK. We established a partnership with several local community stakeholders and they will be responsible for recruiting participants and implementing educational programs. Half of the community collaborators will receive the core intervention package, and use it as education material. The other half will be encouraged to self-collect and send health information to the participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,200 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
For participants recruited by NGOs and companies, the Inclusion Criteria will be: * HK resident aged 18 years or above; * Agreement to participate in the study and provide written informed consent. The Exclusion Criteria will be: * Cognitive impairment that inhibits communication with the investigators; * Inability or unwillingness to provide written informed consent. For participants recruited by schools, the Inclusion Criteria will be: * HK students aged 12 to 18 years and their parents. The Exclusion Criteria will be: * Cannot provide written informed consent (or assent for the younger students).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Hong Kong Polytechnic University
Hung Hom, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Assessing the effectiveness of integration of rapid antigen testing for SARS-CoV-2 in MNCH, HIV and TB services in cameroon and kenya: a pre- and post- implementation evaluation (Effectiveness study)
- A single swab, two diseases: rapid test takes on TB and COVID-19
- A central vault for COVID-19 samples could speed up research
- Can a new vaccine bolster defenses against COVID-19?
- Can new vaccines outsmart COVID-19 variants?
- One shot for two threats: can a single vaccine stop flu and COVID?